Dihydropteridine reductase deficiency

MONDO:0009862

Dihydropteridine reductase (DHPR) deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4), leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties.

Also known as: 6,7-dihydropteridine reductase activity disease, PKU type 2, dihydropteridine reductase deficiency, disorder of 6,7-dihydropteridine reductase activity, hyperphenylalaninemia due to dihydropteridine reductase deficiency, hyperphenylalaninemia, BH4-deficient C, hyperphenylalaninemia, Bh4-deficient, type C, phenylketonuria type 2

25 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by